The following studies are being carried out at the Somerset Foundation Trust.
ASPIRING – Antiplatelet Secondary Prevention International Randomised study after INtracerebral haemorrhaGe
DNA LACUNAR 2 – Genetic risk factors for cerebral small vessel disease
EASE – Evaluating Antidepressants for emotionaliSm after strokE
LACI-3 – Assessment of safety and efficacy of cilostazol and isosorbide mononitrate to prevent recurrent lacunar stroke and progression of cerebral small vessel disease.
LIBREXIA-STROKE – A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
MAPS-2 – Metoclopramide for avoiding pneumonia after stroke
PLORAS – Predicting language outcome and recovery after stroke
RECAST-3 – Remote ischaemic condition after stroke
SMART – Standardised stroke risk assessment for patients with MigrAinous symptoms Reviewed as suspected TIA
TICH-3 – Tranexamic acid for Hyperacute Spontaneous Intracerebral Haemorrhage
